Established in 1990, this Indian manufacturer employs approximately 3,065 individuals and specializes in developing and manufacturing IP-led niche finished dosage formulations. As a CTD dossier owner and manufacturer, it holds GMP certifications from major regulatory authorities, including the US FDA, EU-GMP, Health Canada, and UK MHRA, ensuring compliance with stringent international quality standards. The company operates eight manufacturing units across India, Singapore, Italy, the United States, and Kenya, producing a range of products, including soft gelatin capsules, tablets, and ointments. As a CTD dossier owner and manufacturer, its products are distributed in over 100 countries worldwide.

This pharmaceutical company specializes in a diverse range of products including prescription medications, over-the-counter drugs, medical devices, and supplements. They hold WHO-GMP certifications since 1965 and an ISO 9001:2015 certification, demonstrating their commitment to quality. Their expertise spans various therapy areas such as oncology/hormone therapies, cardiovascular health, and gastrointestinal conditions. They offer a wide range of dosage forms including capsules, tablets, syrups, and rectal suspensions. This company has a global presence, with products distributed across over 2000 countries. They are known for their contract manufacturing capabilities and new drug development expertise, holding over 300 ACTD dossiers.

Established in 2018, this manufacturer employs approximately 653 individuals and specializes in offering end-to-end solutions in the pharmaceutical and specialty chemicals industries. As a CTD dossier owner and manufacturer, it holds GMP approvals from multiple international regulatory authorities, including the U.S. FDA, the Therapeutic Goods Administration (TGA) of Australia, and the Malta Medicines Authority (European Union). Additionally, it has received Written Confirmation from the Central Drugs Standard Control Organization (CDSCO) in India, affirming compliance with EU GMP standards for active pharmaceutical ingredients. The manufacturer operates advanced production lines for active pharmaceutical ingredients (APIs) and formulations, adhering to rigorous GMP guidelines. As a CTD dossier owner and manufacturer, its products and services are utilized across various countries and regions worldwide. With a focus on innovation, efficiency, and agility, the manufacturer is committed to delivering high-standard products that enhance the quality of people's lives.